Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Filings indexed 1,189 across all filing types
Latest filing 2012-11-05 Director's Dealing
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2012-11-05 English
FORM 3
Director's Dealing
2012-11-05 English
FORM 3
Director's Dealing
2012-11-05 English
FORM 10-Q
Interim / Quarterly Report 9M 2012
2012-11-02 English
CURRENT REPORT
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated November 1, 2012. It includes announcements of a new CEO appointment and a new Principal Accounting and Financial Officer, along with details of the CEO's employment agreement. It also references a press release about financial results for the third quarter ended September 30, 2012, and a conference call. The primary content is about management changes and employment agreements, which fits the category of Board/Management Information. The document is not a full financial report, earnings release, or other report type, but rather a regulatory filing announcing management changes. Therefore, the appropriate classification is MANG (Board/Management Information). The document length (6830 characters) supports it being a substantive filing rather than a brief announcement or certification. Confidence is high given the clear content focus on management appointments and agreements.
2012-11-01 English
FORM 4
Director's Dealing
2012-10-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.